Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2013-05-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Attention Bias Modification Treatment for Children With Social Anxiety
NCT01397032
Treatment for Specific Phobias in Children
NCT00051220
Attention Bias Modification Treatment in Social Anxiety
NCT03601377
Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder
NCT01463137
Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth
NCT02460536
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Attention Bias Modification
Training in bias modification for 80% of experimental trials
Attention Bias Modification
Computer delivered modification in 80% of trials
Control
Bias modification for 50% of trials
Attention Bias Modification
Computer delivered modification in 80% of trials
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attention Bias Modification
Computer delivered modification in 80% of trials
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English Speaking
Exclusion Criteria
* Psychosis,
* Autism Spectrum Disorder
11 Years
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Polytechnic Institute and State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas H. Ollendick
Professor - Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas H. Ollendick, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Virginia Polytechnic Institute and State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Child Study Center
Blacksburg, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-180THO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.